|Articles|September 17, 0001
Dual therapy for glaucoma found to be safe, effective
Memphis-Dual therapy with brimonidine (Alphagan, Allergan) andlatanoprost (Xalatan, Pharmacia & Upjohn) was more effective than timolol/dorzolamide(Cosopt, Merck) in reducing IOP in a study of 21 patients being treatedfor glaucoma. The dual therapy also produced greater clinical success asmeasured subjectively by clinicians, according to Peter A. Netland, MD,PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
3
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
4
Study identifies 6 key genes linking air pollution to dry eye disease
5














































.png)


